Makoto Ota
Fondateur chez WELBE, INC.
Fortune : 38 M $ au 30/04/2024
Postes actifs de Makoto Ota
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| WELBE, INC. | Directeur/Membre du Conseil | 01/12/2011 | - |
| Fondateur | 01/12/2011 | - | |
| President | 01/12/2011 | - | |
| Welbe Healthcare, Inc. | Directeur/Membre du Conseil | 01/06/2021 | - |
Historique de carrière de Makoto Ota
Anciens postes connus de Makoto Ota
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TELLA, INC. | Directeur/Membre du Conseil | 01/11/2004 | - |
Statistiques
Internationale
| Japon | 4 |
Opérationnelle
| Director/Board Member | 3 |
| Founder | 1 |
| President | 1 |
Sectorielle
| Health Technology | 2 |
| Commercial Services | 2 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| WELBE, INC. | Commercial Services |
| Entreprise privées | 2 |
|---|---|
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
| Welbe Healthcare, Inc. | Health Services |
- Bourse
- Insiders
- Makoto Ota
- Expérience
